Bruker (BRKR) Stock Price, News & Analysis

Company Overview

Bruker Corporation (NASDAQ:BRKR) is a leading provider of scientific instruments and analytical solutions used in molecular and materials research, as well as in industrial applications and molecular diagnostics. Founded in 1960 in Germany by Dr. Günther Laukien, Bruker has grown through innovation and strategic acquisitions to offer a broad portfolio of technologies, including nuclear magnetic resonance (NMR), mass spectrometry, X-ray diffraction, electron microscopy, and infrared and Raman spectroscopy systems.

The company’s operations are organized into several business segments, each focused on distinct markets. Bruker BioSpin develops high-field NMR spectrometers and preclinical imaging systems for pharmaceutical, academic and biotechnology research. Bruker Daltonics delivers mass spectrometry and chromatography solutions for proteomics, metabolomics, microbiology, and environmental testing. Bruker’s X-ray and Electron Microscopy division produces X-ray diffraction, X-ray fluorescence and electron microscopy instruments critical to materials science, semiconductor research and quality control. Additionally, the company’s molecular diagnostics portfolio includes MALDI Biotyper systems, which support rapid microbial identification in clinical and industrial laboratories.

Headquartered in Billerica, Massachusetts, Bruker maintains a global footprint with research and manufacturing facilities in North America, Europe, and Asia. The company serves customers in more than 90 countries through a combination of direct sales and an extensive network of distributors. Bruker invests heavily in research and development, collaborating with universities, research institutes and industrial partners to drive innovation in areas such as structural biology, nanotechnology and advanced materials characterization.

Under the leadership of Chairman, President and Chief Executive Officer Dr. Frank H. Laukien, Bruker continues to emphasize technological advancement and operational excellence. The management team’s focus on scientific breakthroughs, along with a commitment to quality and customer support, has positioned the company as a trusted partner for researchers and industries seeking precision analytical tools. As a publicly traded company on the NASDAQ, Bruker leverages its expertise in instrumentation and software to address emerging challenges in healthcare, energy, environmental science and beyond.

Key Stats

• Today's Range: $41.04 to $42.35
• 50-Day Range: $35.50 to $43.79
• 52-Week Range: $34.10 to $72.94
• Volume: 2.50 million shs
• Average Volume: 1.78 million shs
• Market Capitalization: $6.39 billion
• P/E Ratio: 81.13
• Dividend Yield: 0.47%
• Price Target: $52.89
• Consensus Rating: Hold

Bruker Stock Analysis - MarketRank™

Bruker scored higher than 99% of companies evaluated by MarketBeat, and ranked 5th out of 665 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.2 / 5
• Analyst Rating: Hold

Consensus Rating

Bruker has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 4 buy ratings, 6 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Bruker has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 17.10%

Earnings Growth

Earnings for Bruker are expected to grow by 17.10% in the coming year, from $2.69 to $3.15 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Bruker is 81.13, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.50.

Price to Earnings Ratio vs. Sector

The P/E ratio of Bruker is 81.13, which means that it is trading at a more expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 33.43.

Price to Earnings Growth Ratio

Bruker has a PEG Ratio of 2.82. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Bruker has a P/B Ratio of 3.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

9.51% of the float of Bruker has been sold short.

Short Interest Ratio / Days to Cover

Bruker has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Bruker has recently decreased by 0.91%, indicating that investor sentiment is improving.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Bruker has a dividend yield of 0.48%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Bruker does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Bruker is 38.46%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Bruker will have a dividend payout ratio of 6.35% next year. This indicates that Bruker will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.8 / 5
• Environmental Score: -1.48

Percentage of Shares Shorted

9.51% of the float of Bruker has been sold short.

Short Interest Ratio / Days to Cover

Bruker has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Bruker has recently decreased by 0.91%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 1.00

News Sentiment

Bruker has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.82 average news sentiment score of Computer and Technology companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for Bruker this week, compared to 10 articles on an average week.

MarketBeat Follows

2 people have added Bruker to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 5.0 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Bruker insiders have bought more of their company's stock than they have sold. Specifically, they have bought $100,043.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

27.30% of the stock of Bruker is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

79.52% of the stock of Bruker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

BRKR Stock Analysis - Frequently Asked Questions

How have BRKR shares performed this year?

Bruker's stock was trading at $58.62 at the start of the year. Since then, BRKR stock has decreased by 28.0% and is now trading at $42.19.

How were Bruker's earnings last quarter?

Bruker Corporation (NASDAQ:BRKR) issued its quarterly earnings results on Wednesday, May, 7th. The medical research company reported $0.47 earnings per share for the quarter, topping analysts' consensus estimates of $0.46 by $0.01. The business's revenue for the quarter was up 11.0% compared to the same quarter last year.
Read the conference call transcript.

Does Bruker have any subsidiaries?

Bruker subsidiaries include these companies: PMOD Technologies, Arxspan, Alicona Imaging, JPK In­stru­ments, Luxendo, Hysitron, InVivo Biotech Services GmbH, and others.

Who are Bruker's major shareholders?

Bruker's top institutional shareholders include Pallas Capital Advisors LLC (6.27%), Public Employees Retirement System of Ohio (0.04%), Wealth Enhancement Advisory Services LLC (0.03%) and Washington Capital Management Inc. (0.01%). Insiders that own company stock include Frank H Laukien, Richard A Packer, Gerald N Herman, Hermann Fritz Requardt, Cynthia M Friend and Thomas Bures.
View institutional ownership trends.

How do I buy shares of Bruker?

Shares of BRKR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Bruker investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AU Optronics (AUOTY).

Company Calendar

• Last Earnings: 5/07/2025
• Record date for 6/27 Dividend: 6/16/2025
• Ex-Dividend for 6/27 Dividend: 6/16/2025
• Dividend Payable: 6/27/2025
• Today: 7/17/2025
• Next Earnings (Estimated): 8/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: INSTRU - SCIENTFC
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NASDAQ:BRKR
• CIK: 1109354
• Web: www.bruker.com
• Phone: (978) 663-3660
• Fax: 978-663-5585
• Employees: 11,396
• Year Founded: 1960

Price Target and Rating

• Average Price Target for Bruker: $52.89
• High Price Target: $72.00
• Low Price Target: $40.00
• Potential Upside/Downside: +26.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.40
• Research Coverage: 10 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.52
• Trailing P/E Ratio: 80.37
• Forward P/E Ratio: 15.51
• P/E Growth: 2.82
• Net Income: $113.10 million
• Net Margins: 2.31%
• Pretax Margin: 4.65%
• Return on Equity: 19.47%
• Return on Assets: 5.95%

Debt

• Debt-to-Equity Ratio: 1.13
• Current Ratio: 1.57
• Quick Ratio: 0.74

Sales & Book Value

• Annual Sales: $3.37 billion
• Price / Sales: 1.88
• Cash Flow: $3.57 per share
• Price / Cash Flow: 11.69
• Book Value: $11.85 per share
• Price / Book: 3.52

Miscellaneous

• Outstanding Shares: 151,530,000
• Free Float: 110,164,000
• Market Cap: $6.32 billion
• Optionable: Optionable
• Beta: 1.18